US 11911403
Antisense-induced exon exclusion in type VII collagen
granted A61KA61K31/70A61P
Quick answer
US patent 11911403 (Antisense-induced exon exclusion in type VII collagen) held by Sarepta Therapeutics, Inc. expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Feb 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/70, A61P, A61P17/00